# Jeffrey L. Probstfield

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jeffrey-l-probstfield/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,593 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 66 |
| i10-index | 151 |
| Last Known Institution | University of Washington |
| OpenAlex ID | https://openalex.org/A5080292021 |
| ORCID iD | https://orcid.org/0000-0002-4899-9971 |
| Works | 230 |

## Researcher papers

Showing 12 of 13.

- [High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.](https://scholariq.org/papers/high-density-lipoprotein-cholesterol-and-cardiovascular-disease-four-prospective/)
- [Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind-a-double-blind/)
- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial](https://scholariq.org/papers/regional-variation-in-patients-and-outcomes-in-the-treatment-of-preserved/)
- [Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-renal-outcomes-in-type-2-diabetes-an-exploratory-analysis-of-the/)
- [Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin](https://scholariq.org/papers/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-randomized-trial-of/)
- [Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma](https://scholariq.org/papers/association-of-angiotensin-converting-enzyme-with-low-density-lipoprotein-in/)
- [Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis](https://scholariq.org/papers/features-of-the-metabolic-syndrome-and-diabetes-mellitus-as-predictors-of-aortic/)
- [Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial](https://scholariq.org/papers/effect-of-dulaglutide-on-cognitive-impairment-in-type-2-diabetes-an-exploratory/)
- [Design and baseline characteristics of participants in the <scp>R</scp> esearching cardiovascular <scp>E</scp> vents with a <scp>W</scp> eekly <scp>IN</scp> cretin in <scp>D</scp> iabetes ( <scp>REWIND</scp> ) trial on the cardiovascular effects of dulaglutide](https://scholariq.org/papers/design-and-baseline-characteristics-of-participants-in-the-scp-r-scp-esearching/)
- [Angiotensin-Converting Enzyme Inhibitors and Change in Aortic Valve Calcium](https://scholariq.org/papers/angiotensin-converting-enzyme-inhibitors-and-change-in-aortic-valve-calcium/)
- [Aortic Valve Calcium Independently Predicts Coronary and Cardiovascular Events in a Primary Prevention Population](https://scholariq.org/papers/aortic-valve-calcium-independently-predicts-coronary-and-cardiovascular-events/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [University of Washington](https://scholariq.org/institutions/university-of-washington/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.